Media-OutReach Newswire VOLUNTARY ANNOUNCEMENT: Uni-GLP Development in Treatment of COVID-19 and Other Indications
Media-OutReach Newswire Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of BioNTech SE’s COVID-19 Vaccine Candidate in Hong Kong and Macau
Media-OutReach Newswire The Lancet Neurology publishes positive results of AFFiRiS' Phase 1 trial with PD01A in Parkinson’s disease patients
Media-OutReach Newswire Inhibiting Inflammatory Responses, Three Scientists Awarded 2020 Tang Prize in Biopharmaceutical Science
Media-OutReach Newswire Abivax: ABX464 inhibits replication of SARS-CoV-2 (COVID-19) in reconstituted human respiratory epithelium model
Media-OutReach Newswire Abivax receives ANSM and Ethics Committee clearance to test its development candidate ABX464 in 1,034 Covid-19 patients in randomized Phase 2b/3 clinical trial